The administrative core will be responsible for all administrative activities of the tPPG and will insure that the program operates according to its objectives and NIH guidelines. The core will be responsible for coordinating all fiscal management and personnel management. The core will also coordinate and schedule regular monthly research conferences, visits by external advisors, meetings of internal advisors and the annual tPPG retreat. The core will also be responsible for the timely renewal and modification of animal research, human research, bio-safety and readiation safety approvals, for insuring the timely training of all new and existing personnel in safe and ethical lab practices and for the coordination and preparation of the annual progress reports. The core will act as the intermediary for all components of the program and to the funding agency to effectively administer and integrate all components of the program and to provide clear, effective and succinct communication.

Public Health Relevance

The core will provide the necessary administrative back-up to maintain effective communication among each of the projects and cores in this grant and between these projects and cores and groups of internal and external advisors and staff at the NHLBI

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL108794-03
Application #
8703757
Study Section
Special Emphasis Panel (ZHL1)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Faust, Hilary E; Golden, Jeffrey A; Rajalingam, Raja et al. (2017) Short lung transplant donor telomere length is associated with decreased CLAD-free survival. Thorax 72:1052-1054
Wei, Ying; Kim, Thomas J; Peng, David H et al. (2017) Fibroblast-specific inhibition of TGF-?1 signaling attenuates lung and tumor fibrosis. J Clin Invest 127:3675-3688
Feldman, Hannah C; Tong, Michael; Wang, Likun et al. (2016) Structural and Functional Analysis of the Allosteric Inhibition of IRE1? with ATP-Competitive Ligands. ACS Chem Biol 11:2195-205
Reed, Nilgun I; Jo, Hyunil; Chen, Chun et al. (2015) The ?v?1 integrin plays a critical in vivo role in tissue fibrosis. Sci Transl Med 7:288ra79
Yang, Jibing; Velikoff, Miranda; Agarwal, Manisha et al. (2015) Overexpression of inhibitor of DNA-binding 2 attenuates pulmonary fibrosis through regulation of c-Abl and Twist. Am J Pathol 185:1001-11
DePianto, Daryle J; Chandriani, Sanjay; Abbas, Alexander R et al. (2015) Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax 70:48-56
Assayag, Deborah; Vittinghoff, Eric; Ryerson, Christopher J et al. (2015) The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis. Respir Med 109:1058-62
Xi, Ying; Tan, Kevin; Brumwell, Alexis N et al. (2014) Inhibition of epithelial-to-mesenchymal transition and pulmonary fibrosis by methacycline. Am J Respir Cell Mol Biol 50:51-60
Wolters, Paul J; Collard, Harold R; Jones, Kirk D (2014) Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 9:157-79
Travis, Mark A; Sheppard, Dean (2014) TGF-? activation and function in immunity. Annu Rev Immunol 32:51-82

Showing the most recent 10 out of 17 publications